Old Web
English
Sign In
Acemap
>
authorDetail
>
Margaret Fedgchin
Margaret Fedgchin
Merck & Co.
Aprepitant
Pharmacology
Medicine
CYP3A4
Docetaxel
3
Papers
69
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant
2011
Cancer Chemotherapy and Pharmacology
S. Aubrey Stoch
Cynthia Gargano
Jack Valentine
Matthew P. Braun
M. Gail Murphy
Margaret Fedgchin
Anup Majumdar
Edward Pequignot
Keith M. Gottesdiener
Kevin J. Petty
Deborah Panebianco
Dennis C. Dean
Walter K. Kraft
Howard E. Greenberg
Show All
Source
Cite
Save
Citations (9)
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
2005
Cancer Chemotherapy and Pharmacology
Peter Nygren
Kenneth R. Hande
Kevin J. Petty
Margaret Fedgchin
Kristien Van Dyck
Anup Majumdar
Debbie Panebianco
Marina De Smet
Tuli Ahmed
M. Gail Murphy
Keith M. Gottesdiener
Veronique Cocquyt
Simon Van Belle
Show All
Source
Cite
Save
Citations (60)
An open-label, balanced, 2-period crossover study to investigate the influence of aprepitant on docetaxel pharmacokinetics
2004
Journal of Clinical Oncology
Kenneth R. Hande
Peter Nygren
Margaret Fedgchin
K. Vandyck
Anup Majumdar
D. Panebianco
Kevin J. Petty
M. Sjolund
Veronique Cocquyt
S. VanBelle
Show All
Source
Cite
Save
Citations (0)
1